Fmr LLC Buys 1,170,202 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Fmr LLC lifted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 55,963.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,172,293 shares of the financial services provider’s stock after purchasing an additional 1,170,202 shares during the period. Fmr LLC’s holdings in Trupanion were worth $49,213,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Quest Partners LLC bought a new position in Trupanion during the third quarter worth about $37,000. GAMMA Investing LLC increased its holdings in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares during the last quarter. Headlands Technologies LLC bought a new stake in Trupanion in the 2nd quarter valued at $162,000. Entropy Technologies LP acquired a new stake in Trupanion during the 3rd quarter valued at $202,000. Finally, Mutual of America Capital Management LLC bought a new position in Trupanion during the third quarter worth $210,000.

Trupanion Stock Performance

NASDAQ TRUP opened at $53.46 on Friday. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The firm has a 50-day moving average price of $51.08 and a two-hundred day moving average price of $41.11. The company has a market capitalization of $2.26 billion, a P/E ratio of -167.06 and a beta of 1.60. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the previous year, the company posted ($0.10) earnings per share. The firm’s revenue for the quarter was up 14.6% compared to the same quarter last year. Analysts anticipate that Trupanion, Inc. will post -0.23 earnings per share for the current year.

Insider Buying and Selling

In other Trupanion news, Director Murray B. Low sold 2,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the sale, the director now directly owns 131,513 shares in the company, valued at $6,926,789.71. This represents a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,405 shares of company stock worth $1,512,482. Company insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on TRUP shares. Piper Sandler increased their price objective on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Northland Securities raised their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus boosted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Finally, Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $44.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.